EJNMMI Research
Scope & Guideline
Connecting Theory with Practice in Cutting-Edge Research.
Introduction
Aims and Scopes
- Molecular Imaging Techniques:
The journal emphasizes innovative imaging modalities, including positron emission tomography (PET), single-photon emission computed tomography (SPECT), and hybrid imaging techniques, which are crucial for diagnosing and monitoring diseases. - Radiopharmaceutical Development:
A significant focus is on the development and validation of new radiopharmaceuticals for both diagnostic and therapeutic applications, with an aim to improve imaging accuracy and patient outcomes. - Clinical Applications and Trials:
EJNMMI Research publishes studies that explore the clinical applications of imaging technologies, including their role in oncology, neurology, cardiology, and other fields, as well as the results from clinical trials. - Quantitative Imaging and Dosimetry:
The journal covers advances in quantitative imaging methodologies and dosimetry, which are essential for optimizing treatment plans in personalized medicine. - Theranostics:
The integration of diagnostics and therapeutics, or theranostics, is a key area of research, focusing on the use of imaging to guide targeted therapies. - Artificial Intelligence and Imaging:
There is a growing interest in the application of artificial intelligence and machine learning techniques to enhance imaging analysis and interpretation, which is a significant trend within the journal.
Trending and Emerging
- Artificial Intelligence in Imaging:
The application of AI and machine learning for image reconstruction, analysis, and interpretation is rapidly gaining traction, as these technologies enhance diagnostic accuracy and efficiency. - Radiomics and Imaging Biomarkers:
The exploration of radiomics, which involves extracting a large number of features from medical images, is trending as a method for improving diagnosis and predicting treatment outcomes. - Personalized Medicine:
There is an increasing emphasis on personalized approaches in nuclear medicine, particularly in the context of cancer therapies that are tailored based on individual patient imaging and genetic profiles. - Theranostic Approaches:
The integration of diagnostic and therapeutic strategies, particularly using radioligands for targeted therapy, is emerging as a significant theme, reflecting the trend toward personalized treatment plans. - Hybrid Imaging Technologies:
The continued development and application of hybrid imaging technologies, such as PET/MRI and PET/CT, are trending, allowing for comprehensive assessments of complex diseases. - Immuno-PET Techniques:
The use of immuno-PET for evaluating immune responses and targeting specific biomarkers is gaining popularity, reflecting a broader interest in immunotherapy and its monitoring.
Declining or Waning
- Traditional Imaging Techniques:
There has been a noticeable decrease in publications focused exclusively on traditional imaging methods without the integration of newer technologies or advanced imaging analysis techniques. - Invasive Imaging Procedures:
Research papers emphasizing invasive imaging procedures are becoming less common as non-invasive techniques gain favor for their lower risk and improved patient comfort. - Basic Science Studies:
There has been a waning interest in purely basic science studies that do not translate directly to clinical applications, as the journal increasingly prioritizes translational research. - Non-targeted Imaging Agents:
The focus on non-specific or non-targeted imaging agents is decreasing, with a shift towards more personalized and targeted approaches in imaging.
Similar Journals
JOURNAL OF THORACIC IMAGING
Connecting Research and Practice in Thoracic ImagingThe JOURNAL OF THORACIC IMAGING, published by Lippincott Williams & Wilkins, stands as a pivotal resource in the fields of Pulmonary and Respiratory Medicine as well as Radiology, Nuclear Medicine, and Imaging. With the ISSN 0883-5993 and E-ISSN 1536-0237, this esteemed journal has been providing critical insights and advancements since its inception in 1985, contributing significantly to the ongoing dialogue and research within these disciplines. The journal maintains a commendable position, ranking in the Q2 category in both relevant fields and achieving an impressive Scopus ranking of #46 out of 333 in Radiology and #30 out of 155 in Pulmonary Medicine, showcasing its influence and impact (with particles in the 86th and 80th percentiles, respectively). While the journal is not open access, it continues to disseminate high-quality research that informs clinical best practices and emerging technologies in thoracic imaging. As a leading publication, it serves as an essential tool for researchers, clinicians, and students seeking to stay at the forefront of thoracic health innovations.
RADIOGRAPHICS
Empowering Radiologists with Cutting-edge ResearchRADIOGRAPHICS, published by the Radiological Society of North America (RSNA), is a premier academic journal dedicated to the field of radiology, nuclear medicine, and imaging. With an impressive impact factor and recognition in the top quartile (Q1) of both Medicine (miscellaneous) and Radiology, Nuclear Medicine and Imaging categories, RADIOGRAPHICS stands out as a leading platform for disseminating high-quality research and clinical findings. Since its inception in 1985 and projected to run until 2024, the journal has consistently provided essential insights into cutting-edge imaging techniques and advancements in radiological practices, making it invaluable for professionals, researchers, and students alike. Although it does not offer open access, the journal continues to flourish with a robust reputation, ranked 35th in its field according to Scopus, placing it within the 89th percentile of its category. With an unwavering commitment to enhancing the understanding and application of radiological sciences, RADIOGRAPHICS remains a pivotal resource for advancing knowledge and expertise within the medical community.
NUCLEAR MEDICINE COMMUNICATIONS
Fostering Scholarly Exchange in Nuclear MedicineNUCLEAR MEDICINE COMMUNICATIONS is a prestigious academic journal published by Lippincott Williams & Wilkins, focusing on the multifaceted field of nuclear medicine and its applications in diagnostics and therapy. With a solid history spanning from 1980 to 2024, this journal provides a platform for peer-reviewed research articles, clinical studies, and innovative techniques that enrich the knowledge base within the fields of {{medicinal applications, patient care, and imaging technology}}. Currently classified in the Q3 quartile for both Medicine (Miscellaneous) and Radiology, Nuclear Medicine, and Imaging, the journal reflects its commitment to advancing healthcare practices. Although it does not offer open access options, its accessibility through reputable institutions promotes scholarly exchange among researchers, professionals, and students alike. The critical insights provided in NUCLEAR MEDICINE COMMUNICATIONS are essential for those dedicated to enhancing patient outcomes through cutting-edge nuclear medical technologies.
CLINICAL NUCLEAR MEDICINE
Navigating the Evolving Landscape of Nuclear MedicineCLINICAL NUCLEAR MEDICINE is a premier journal dedicated to the field of nuclear medicine, published by Lippincott Williams & Wilkins. With a history of excellence since its inception in 1978, the journal serves as a vital resource for researchers, healthcare professionals, and students seeking to deepen their understanding of this rapidly evolving discipline. The journal holds a commendable Q2 ranking in both Medicine (miscellaneous) and Radiology, Nuclear Medicine and Imaging, reflecting its significant impact on advancing clinical practices and research. While currently not offered as an open-access publication, CLINICAL NUCLEAR MEDICINE ensures rigorous peer review and high-quality publications, contributing to the broad dissemination of cutting-edge studies and reviews. With its comprehensive scope encompassing both diagnostic and therapeutic nuclear medicine applications, researchers around the globe turn to this journal to stay informed and inspire innovations in patient care for the years leading up to 2024 and beyond.
Nuclear Medicine and Molecular Imaging
Pioneering Discoveries in Molecular Imaging TechniquesNuclear Medicine and Molecular Imaging, published by SPRINGER HEIDELBERG, stands as a pivotal platform in the interdisciplinary field of radiology and nuclear medicine, focusing on innovative research and developments from 2010 to 2024. With its ISSN 1869-3474 and E-ISSN 1869-3482, this journal aims to disseminate advanced studies that explore the diagnostic and therapeutic applications of nuclear medicine technologies. Operating from Germany, it has positioned itself in the Q3 category within the Radiology, Nuclear Medicine and Imaging sector, showcasing its relevance among peer journals, with a Scopus rank of #204 out of 333. This journal not only serves as an essential resource for researchers and practitioners eager to stay abreast of modern methodologies and findings but also underscores the crucial advancements in molecular imaging techniques. Although currently not an open-access journal, it doesn't detract from its mission to promote knowledge exchange among academia and the medical community, thus paving the way for innovative solutions and improved patient care in nuclear medicine.
NUCLEAR MEDICINE AND BIOLOGY
Pioneering research at the intersection of medicine and biology.NUCLEAR MEDICINE AND BIOLOGY, published by Elsevier Science Inc, is a premier journal dedicated to advancing the fields of nuclear medicine and molecular biology. Since its inception in 1986, this journal has served as a vital platform for the dissemination of high-quality research, with a clear focus on the innovative applications of nuclear techniques in biological settings. It is categorized in the Q3 tier for both Cancer Research and Molecular Medicine, and Q2 for Radiology, Nuclear Medicine and Imaging, highlighting its significant standing within these disciplines. The journal's Scopus rankings reflect its strong impact, placing it in the top quartile of its categories, particularly in Radiology, Nuclear Medicine, and Imaging. Researchers, professionals, and students alike will find this an invaluable resource for contemporary research findings and methodologies in nuclear medicine and its biological applications. Access to the journal is provided through subscription, ensuring that quality content remains available to its wide-ranging audience.
SEMINARS IN ULTRASOUND CT AND MRI
Advancing the Frontiers of Diagnostic ImagingSEMINARS IN ULTRASOUND CT AND MRI is a prestigious academic journal dedicated to advancing the fields of radiology, nuclear medicine, and imaging. Published by W B SAUNDERS CO-ELSEVIER INC, this journal has been a cornerstone of scholarly communication since 1984, providing a platform for high-quality research and review articles that enhance the understanding of diagnostic imaging techniques. With a current impact factor reflected in its Q3 quartile ranking among 333 journals in its category, it remains a valuable resource for researchers and clinicians alike. The journal's focus includes but is not limited to innovations in ultrasound, computed tomography, and magnetic resonance imaging, making it essential for professionals looking to stay at the forefront of imaging science. While it operates under a subscription model, its extensive archive of influential articles ensures ongoing access to critical knowledge and developments in the field. With a commitment to quality and relevance, SEMINARS IN ULTRASOUND CT AND MRI continues to contribute significantly to the evolving landscape of medical imaging.
NUKLEARMEDIZIN-NUCLEAR MEDICINE
Advancing the Frontiers of Nuclear Medicine.NUKLEARMEDIZIN-NUCLEAR MEDICINE is a prestigious journal published by Georg Thieme Verlag KG, focusing on pivotal advancements in the fields of Nuclear Medicine, Radiology, and Imaging. Established in 1959, this journal has served as a critical platform for disseminating innovative research, reviews, and clinical guidelines until its anticipated convergence in 2024. With an ISSN of 0029-5566 and an E-ISSN of 2567-6407, NUKLEARMEDIZIN is acknowledged in the academic community as a Q3 category journal within Medicine (miscellaneous) and Radiology, Nuclear Medicine, and Imaging as of 2023, highlighting its ongoing contribution to the interdisciplinary dialogue in healthcare. Although the journal does not currently offer open access, it remains accessible to professionals and students through various academic databases, ensuring that cutting-edge knowledge in this growing field is shared widely. Researchers interested in the latest methods and technologies in Nuclear Medicine will find NUKLEARMEDIZIN a valuable resource for enhancing their work and understanding the complexities of modern imaging modalities.
Current Radiology Reports
Connecting researchers with transformative radiological discoveries.Current Radiology Reports is an esteemed journal published by SPRINGERNATURE, focusing on the dynamic field of radiology, nuclear medicine, and imaging. With a commitment to advancing knowledge and promoting innovative practices, this journal serves as a valuable resource for researchers, healthcare professionals, and students striving to stay at the forefront of radiological advancements. Featuring an impressive impact factor and recognized as a Q3 journal within its category as of 2023, it highlights critical developments and comprehensive reviews that inform clinical practice and research methodologies. Although it operates under a subscription model, the journal provides a rich repository of peer-reviewed content, covering a wide range of topics from diagnostic imaging to therapeutic applications. With a publication span from 2013 to 2024, Current Radiology Reports continues to uphold its reputation as a leading publication critical for anyone involved in the radiology profession.
PET Clinics
Advancing the Frontiers of PET Imaging.PET Clinics, published by Elsevier Inc, is a premier academic journal focusing on the advancements and applications of Positron Emission Tomography (PET) in various medical fields. With its ISSN 1556-8598 and E-ISSN 1559-7814, the journal has established a strong reputation in the scientific community, reflected in its impressive Q1 quartile rankings in Medicine (miscellaneous), Radiation, and Radiology, Nuclear Medicine, and Imaging for 2023. The journal operates within a well-defined scope that bridges innovative research and practical clinical applications, targeting professionals, researchers, and students keen on the intersection of nuclear medicine and imaging technologies. Although not an open-access journal, PET Clinics ensures accessibility through institutional subscriptions, making valuable insights available to the academic community. With an emphasis on enhancing patient care and treatment outcomes through cutting-edge imaging techniques, this journal serves as an essential resource for those seeking to expand their knowledge and expertise in the rapidly evolving field of PET.